Front Row Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Front Row Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92K	Hold	100	–	–	﹤0.01%	498
2025 Q4	$2.2K	Hold	100	–	–	﹤0.01%	484
2025 Q3	$1.21K	Hold	100	–	–	﹤0.01%	504
2025 Q2	$1.86K	Hold	100	–	–	﹤0.01%	470
2025 Q1	$1.92K	Hold	100	–	–	﹤0.01%	449
2024 Q4	$3.6K	Hold	100	–	–	﹤0.01%	422
2024 Q3	$4.24K	Sell	100 -188	-65%	-$7.97K	﹤0.01%	416
2024 Q2	$11.6K	Sell	288 -27	-9%	-$1.13K	﹤0.01%	537
2024 Q1	$11.2K	Buy	315 +215	+215%	+$5.76K	﹤0.01%	556
2023 Q4	$2.96K	Hold	100	–	–	﹤0.01%	397
2023 Q3	$2.08K	Hold	100	–	–	﹤0.01%	812
2023 Q2	$2K	Hold	100	–	–	﹤0.01%	825
2023 Q1	$4K	Hold	100	–	–	﹤0.01%	736
2022 Q4	$4K	Hold	100	–	–	﹤0.01%	702
2022 Q3	$5K	Hold	100	–	–	﹤0.01%	665
2022 Q2	$6K	Hold	100	–	–	﹤0.01%	642
2022 Q1	$12K	Hold	100	–	–	﹤0.01%	526
2021 Q4	$15K	Hold	100	–	–	0.01%	485
2021 Q3	$12K	Hold	100	–	–	0.01%	522
2021 Q2	$11K	Hold	100	–	–	﹤0.01%	549
2021 Q1	$9K	Hold	100	–	–	﹤0.01%	579
2020 Q4	$10K	Hold	100	–	–	0.01%	531
2020 Q3	$9K	Hold	100	–	–	﹤0.01%	546
2020 Q2	$10K	Hold	100	–	–	0.01%	477
2020 Q1	$8K	Hold	100	–	–	0.01%	522
2019 Q4	$6K	Hold	100	–	–	﹤0.01%	591
2019 Q3	$6K	Hold	100	–	–	﹤0.01%	569
2019 Q2	$6K	Hold	100	–	–	﹤0.01%	558
2019 Q1	$6K	Hold	100	–	–	﹤0.01%	551
2018 Q4	$4K	Hold	100	–	–	﹤0.01%	614
2018 Q3	$3	Buy	+100	New	+$3.49K	﹤0.01%	733

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Front Row Advisors's TNDM Position: Q1 2026 in Review

Front Row Advisors held its Tandem Diabetes Care (TNDM) position steady in Q1 2026 at 100 shares worth $1.92K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Front Row Advisors first reported a position in TNDM in Q3 2018 and has held it in 31 quarters since. The position peaked at $15K in Q4 2021. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

Front Row Advisors held 100 shares of Tandem Diabetes Care worth $1.92K as of Q1 2026.
Front Row Advisors left its Tandem Diabetes Care share count unchanged in Q1 2026.
Tandem Diabetes Care made up ﹤0.01% of Front Row Advisors's portfolio in Q1 2026, its #498 holding.
Front Row Advisors first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 31 quarters since.
Front Row Advisors's Tandem Diabetes Care position peaked at $15K in Q4 2021.
272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.